Dutch Startup and Venture Challenge alumnus Cyclomics Developing Liquid Biopsy Assay Using Nanopore Sequencing
Dutch startup Cyclomics is developing a liquid biopsy test for tumor recurrence and therapy response monitoring that…
Dutch startup Cyclomics is developing a liquid biopsy test for tumor recurrence and therapy response monitoring that…
Ncardia, winner of the Venture Challenge 2009, announced today that following retraction of the Cor.4U product line…
The Interreg project Codex4SMEs (Companion diagnostics expedited for small and medium-sized businesses) project plans to improve healthcare…
The Association of Dutch Health Foundations (SGF) and the Top Sector Life Sciences & Health (LSH) have made €…
Khondrion granted Orphan Drug Designation for KH176 for the treatment of maternally inherited diabetes and deafness (MIDD)…
Recent Comments